Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 02, 2023

Tumour-Infiltrating Lymphocyte Density as a Predictive Biomarker of Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer

British Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial
Br. J. Cancer 2023 Apr 07;[EPub Ahead of Print], DHW Liu, YW Kim, N Sefcovicova, JP Laye, LC Hewitt, AF Irvine, V Vromen, Y Janssen, N Davarzani, GE Fazzi, S Jolani, V Melotte, DR Magee, MC Kook, H Kim, R Langer, JH Cheong, HI Grabsch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading